Literature DB >> 6369482

Oral candidiasis: pathogenesis and host defense.

J B Epstein, E L Truelove, K T Izutzu.   

Abstract

Oral candidiasis is a common problem, frequently presenting as a chronic recurring infection. Oral infection is a potential reservoir of organisms for severe, spreading, local disease and systemic disease in the compromised host. Nonspecific local oral factors in host defense include the epithelial barrier, flow or saliva, microbial interactions, antimicrobial constituents of saliva, lysozyme, lactoferrin, the lactoperoxidase system, levels of iron, and salivary glycoproteins. Immunoglobins are present in saliva, but their role is poorly understood. The activity of antibody against Candida on oral mucosal surfaces may not be mediated by complement and phagocyte activity. Specific antibodies against Candida may function by aggregating the organisms and preventing mucosal adherence of the fungi.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6369482     DOI: 10.1093/clinids/6.1.96

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  18 in total

1.  Dialysis unmasks the fungicidal properties of glandular salivary secretions.

Authors:  Eva J Helmerhorst; Bianca Flora; Robert F Troxler; Frank G Oppenheim
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

2.  Cellular and cytokine correlates of mucosal protection in murine model of oral candidiasis.

Authors:  S Elahi; G Pang; R Clancy; R B Ashman
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

3.  Semi-interpenetrating network (sIPN) gelatin nanofiber scaffolds for oral mucosal drug delivery.

Authors:  Donald C Aduba; Jeremy A Hammer; Quan Yuan; W Andrew Yeudall; Gary L Bowlin; Hu Yang
Journal:  Acta Biomater       Date:  2013-02-13       Impact factor: 8.947

4.  Enhanced clearance of Candida albicans from the oral cavities of mice following oral administration of Lactobacillus acidophilus.

Authors:  S Elahi; G Pang; R Ashman; R Clancy
Journal:  Clin Exp Immunol       Date:  2005-07       Impact factor: 4.330

5.  Oral manifestations of human immunodeficiency virus infection.

Authors:  J B Epstein; R G Mathias
Journal:  Can Fam Physician       Date:  1988-08       Impact factor: 3.275

6.  Poly(I.C)-induced interferons enhance susceptibility of SCID mice to systemic candidiasis.

Authors:  J Jensen; A Vazquez-Torres; E Balish
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

7.  Killing of Candida albicans by lactoferricin B, a potent antimicrobial peptide derived from the N-terminal region of bovine lactoferrin.

Authors:  W Bellamy; H Wakabayashi; M Takase; K Kawase; S Shimamura; M Tomita
Journal:  Med Microbiol Immunol       Date:  1993-05       Impact factor: 3.402

8.  Factors influencing the interaction of Candida albicans with fibroblast cell cultures.

Authors:  G J Merkel; C L Phelps
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

9.  Anticandidal activity of major human salivary histatins.

Authors:  T Xu; S M Levitz; R D Diamond; F G Oppenheim
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

10.  Microtiter broth dilution method for yeast susceptibility testing with validation by clinical outcome.

Authors:  M Radetsky; R C Wheeler; M H Roe; J K Todd
Journal:  J Clin Microbiol       Date:  1986-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.